KETAMINE HCL DRUG UNDER SCHEDULE X
KETAMINE HCL DRUG UNDER SCHEDULE X
KETAMINE HCL DRUG UNDER SCHEDULE X Read More »
KETAMINE HCL DRUG UNDER SCHEDULE X
KETAMINE HCL DRUG UNDER SCHEDULE X Read More »
Amendment of the Drugs and Cosmectics Rules relating to prohibition of testing of cosmetics on animals-regarding
Notification under Section 26A restricting the sale of Oxytocin drug
Notification under Section 26A restricting the sale of Oxytocin drug Read More »
FDA OFFICE TO SHIFT TO BAMBOLIM
FDA OFFICE TO SHIFT TO BAMBOLIM Read More »
“Revocation of suspension of the Notification no. G.S.R. 378(E) dated 18/06/2013.” E) dated 18/06/2013.”
Prohibition of manufacture for sale, sale and distribution of Fixed dose combination of Flupenthixol and Melitracen for human use
NOTIFICATION ON MEDICAL DEVICES
NOTIFICATION ON MEDICAL DEVICES Read More »